Safety and Tolerability of ZE74-0282 in Healthy Volunteers
Safety and Tolerability of ZE74-0282 in Healthy Volunteers
Recruiting · NCT07527221 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability of ZE74-0282 in Healthy Volunteers | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, leukemia, myeloid leukemia, neoplasm, polycythemia, primary myelofibrosis, thrombocytosis disease | Recruiting | Phase 1 | 2026-07-28 | NCT07527221 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eilean Therapeutics AU Pty Ltd | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Scientia Clinical Research Ltd. | Randwick | Australia | 2 |